NCT03075423 2025-09-26Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCCGoethe UniversityPhase 2 Completed316 enrolled
NCT03154190 2025-01-24Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerStanford UniversityPhase NA Completed128 enrolled 24 charts
NCT02187302 2020-05-28CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)Lumos PharmaPhase 2 Completed115 enrolled